Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Asthma
Researchers' work adds to asthma body of knowledge
March 24th, 2006
Asthma data are the focus of recent research from Japan, the United States and France. Study 1: Montelukast combined with short-acting beta2 agonists may provide effective treatment option in mild-to-moderate childhood asthma. "Asthma is a chronic inflammatory airway disease. Exhaled nitric oxide (eNO) is a marker reflecting airway inflammation," scientists in Japan report. "This study was conducted to investigate whether montelukast, a leukotriene receptor antagonist, could be used for the management of asthma and how fast the montelukast sodium decreased airway inflammation as demonstrated by eNO levels," wrote M.Y. Lee and...
Source: Drug Week (2006-03-24)
|
